MedTrace Logo

Combined Circulatory and Dietary Interventions for Neuropathy

NCT07213843 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-10-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of three different interventions in improving neuropathy symptoms in individuals aged 35-85 with moderate to severe neuropathy. The study will compare three treatment groups: Intraneural Facilitation® (INF®) therapy alone, INF® therapy combined with Neuro vascular index (NVI) food-guided elimination (NVIf), and NVIf alone. The aim is to determine which treatment results in the greatest improvement in neuropathy symptoms, including quality of life, sensory and pain improvements, and functional outcomes.

Conditions

  • Diabete Type 2
  • Neuropathy, Painful

Interventions

OTHER

INF® Therapy

INF® therapy is a manual technique designed to improve neural circulation by using a series of manual holds administered by a trained practitioner,

OTHER

NVIf

NVIf is a dietary intervention that uses a patented ultrasound technology to assess vascular responses to food allergens

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Kyan Sahba, PhD · Loma Linda University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-01
Primary Completion
2028-10-01
Completion
2028-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07213843 on ClinicalTrials.gov